In our previous studies, we demonstrated that silencing VDAC1 expression using specific siRNA against human VDAC1 and mouse models of lung, glioblastoma, breast cancer, and others inhibited tumor growth and induced reprogrammed metabolism [14,15,16,17]. This evidence concerns the gene VDAC1 and breast carcinoma.